CYCLOPHOSPHAMIDE, DOXORUBICIN, AND VINCRISTINE IN ETOPOSIDE-RESISTANT AND CISPLATIN-RESISTANT SMALL-CELL LUNG-CANCER

被引：1

作者：

SHEPHERD, FA

EVANS, WK

MACCORMICK, R

FELD, R

YAU, JC

机构：

[1] ONTARIO CANC TREATMENT & RES FDN,OTTAWA,ONTARIO,CANADA

[2] TORONTO GEN HOSP,DEPT MED,TORONTO M5G 1L7,ONTARIO,CANADA

来源：

CANCER TREATMENT REPORTS | 1987年 / 71卷 / 10期

关键词：

D O I：

暂无

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：941 / 944

页数：4

共 17 条

[1]

BLEEHEN NM, 1986, CHEST S, V89, P2685

[2] CYCLIC ALTERNATING NON-CROSS RESISTANT CHEMOTHERAPY IN THE MANAGEMENT OF SMALL CELL ANAPLASTIC CARCINOMA OF THE LUNG [J].

ELLIOTT, JA ;

OSTERLIND, K ;

HANSEN, HH .

CANCER TREATMENT REVIEWS, 1984, 11 (02) :103-113

[3]

EVANS W K, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P169

[4] VP-16 AND CISPLATIN AS 1ST-LINE THERAPY FOR SMALL-CELL LUNG-CANCER [J].

EVANS, WK ;

SHEPHERD, FA ;

FELD, R ;

OSOBA, D ;

DANG, P ;

DEBOER, G .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (11) :1471-1477

[5] ETOPOSIDE (VP-16) AND CISPLATIN - AN EFFECTIVE TREATMENT FOR RELAPSE IN SMALL-CELL LUNG-CANCER [J].

EVANS, WK ;

OSOBA, D ;

FELD, R ;

SHEPHERD, FA ;

BAZOS, MJ ;

DEBOER, G .

JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (01) :65-71

[6]

FELD R, 1981, ARCH INTERN MED, V242, P469

[7]

FELD R, 1985, P AN M AM SOC CLIN, V4, P177

[8]

GOLDIE JH, 1982, CANCER TREAT REP, V66, P439

[9]

GOODMAN G E, 1986, Proceedings American Society of Clinical Oncology Annual Meeting, V5, P169

[10]

Ihde D C, 1984, Cancer, V54, P2722, DOI 10.1002/1097-0142(19841201)54:2+<2722::AID-CNCR2820541419>3.0.CO

← 1 2 →